International Clinical Trial: An exploratory study to evaluate the tolerability, safety, and efficacy of ¹77Lu-HGC254 in patients with advanced solid tumors

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132914) titled 'An exploratory study to evaluate the tolerability, safety, and efficacy of ¹77Lu-HGC254 in patients with advanced solid tumors' on Sept. 20.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Hospital of Sichuan University

Condition: Advanced solid tumors

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-08

Target Sample Size: Treatment group:10;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=343363

Published by HT Digital Content Services with permission from Health Daily Diges...